Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Thoracic and Cardiovascular Surgery|January 14, 2015
Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgeryDuc Ha, Humberto Choi, Katrina Zell, et al.Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic featuresMohammadhadi Khorrami, Prantesh Jain, Kaustav Bera, et al.NPJ Precision Oncology|December 24, 2024
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLCLukas Delasos, Mohammadhadi Khorrami, Vidya S Viswanathan, et al.American Journal of Clinical Oncology|March 14, 2023
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary MetastasesWafa Asha, Sami Koro, Zachary Mayo, et al.JCO Clinical Cancer Informatics|June 27, 2023
Clinical Nomogram Using Novel Computed Tomography-Based Radiomics Predicts Survival in Patients With Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiation TherapyEashwar Somasundaram, Raoul R Wadhwa, Adam Litzler, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012Shannon E Fogh, Snehal Deshmukh, Lawrence B Berk, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 2025
International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?Salem A Alfaifi, Alexander V Louie, Shankar Siva, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Multicentre results of stereotactic body radiotherapy for secondary liver tumoursBetul Berber, Rafael Ibarra, Laura Snyder, et al.Acta Oncologica (Stockholm, Sweden)|January 24, 2012
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumorsRafael A Ibarra, Daniel Rojas, Laura Snyder, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.Pageof 4